Haemolytic Disease of the Newborn

PEDIATRICS ◽  
1957 ◽  
Vol 20 (4) ◽  
pp. 675-675

Two well-known authorities on hemolytic disease undertake in this paper to determine the causes for what they consider to be an excessive mortality from this disease in England and Wales at the present time. They state that with correct use of exchange transfusion a mortality of not more than 5% of infants with hemolytic disease born alive should be expected. The authors express the opinion that the deaths at present are at least three times as numerous as should be expected with modern treatment. Analysis of the reported deaths seem to indicate two principal causes for this: (1) failure to anticipate the disease before birth or to recognize the disease early after birth, and (2) either failure to undertake an exchange transfusion or to employ satisfactory technique in the exchange transfusion, particularly to give an adequate exchange. They point out that the best results are to be expected in hospitals where a large number of cases are treated and considerable experience is acquired. In hospitals where the number of cases seen is small it is difficult for the staff to gain the necessary experience and familiarity with the technique of exchange transfusion and the general principles of diagnosis and management. A full discussion of the essential points in prediction and diagnosis of the disorder and of the indications for exchange transfusion, with emphasis on the volumes of blood to be exchanged, are given.

Vox Sanguinis ◽  
2021 ◽  
Author(s):  
Jon F. Watchko ◽  
M. Jeffrey Maisels

2007 ◽  
Vol 1 (2) ◽  
pp. 56 ◽  
Author(s):  
DC Sharma ◽  
Sunita Rai ◽  
Aakash Mehra ◽  
MM Kaur ◽  
Satya Sao ◽  
...  

PEDIATRICS ◽  
1949 ◽  
Vol 4 (2) ◽  
pp. 265-265

Mitchell, N., et al., Congenital hemolytic disease resulting from A-O isoimmunization, Pediatrics 3:813, 1949. The mother in Case 2 has been delivered of another child just a few weeks ago. The infant was born with jaundice and on the second day of life an exchange transfusion was carried out with apparently good results. The infant is at present alive and healthy. Line 21 on page 818 should read "present three cases" instead of "two fatal cases."


PEDIATRICS ◽  
1972 ◽  
Vol 50 (1) ◽  
pp. 165-165
Author(s):  
Philip Lanzkowsky

I regret that Dr. Ente has misunderstood both the content and the intent of our paper. We never stated that anemia in hemolytic disease is the fault of phototherapy, but stated that it was the consequence of multiple factors such as transient erythroblastopenia, splenic sequestration, and continuous hemolysis, and was well recognized before the use of phototherapy. The intent of the paper was, not to blame the therapy, but to caution the physican about the need to do frequent bilirubin and hemoglobin estimations in hemolytic disease of the newborn, especially when the infant has had phototherapy and therefore may not require an exchange transfusion.


PEDIATRICS ◽  
1964 ◽  
Vol 34 (5) ◽  
pp. 664-669
Author(s):  
Donald L. Goldfarb ◽  
Victor Ginsberg ◽  
Mary Kaufman ◽  
Margaret G. Robinson ◽  
R. Janet Watson

Twenty-four infants with hemolytic disease of the newborn due to ABO incompatibility requiring exchange transfusion were treated randomly with either group O blood low in titer for iso-antibodies or washed packed group O erythrocytes resuspended in group AB plasma. No significant differences in survival, sequelae, number of exchange transfusions required or the course of postexchange bilirubin levels was observed. It is concluded that group O cells in AB plasma is not an improvement over conventional group O blood.


PEDIATRICS ◽  
1956 ◽  
Vol 17 (3) ◽  
pp. 449-449

Exchange transfusions in hemolytic disease of the newborn are now generally accepted as the proper procedure for reducing the mortality and morbidity of this entity. It is our experience that more and more hospitals with active newborn services are carrying out this procedure themselves rather than transferring the patient to pediatric centers. For this reason the technique should be standardized and simplified as much as possible.


2015 ◽  
Vol 3 (2) ◽  
pp. 293-297 ◽  
Author(s):  
Emilija Velkova

AIM: The aim of this study was to investigate the influence of subclasses to IgG anti-D on the intensity of hemolytic disease of fetus and newborn (HDFN) at 45 fetuses/newborns with symptoms of mild and severe HDFN in Republic of Macedonia.MATERIAL AND METHODS: In retrospective and prospective studies, in a period of 10 years, from 2004 to 2014, there have been immunohemathology tests performed on 22 009 samples on serums of pregnant women.RESULTS: At 37.78% of the total number of tested patients, IgG1 and IgG3 was the reason for severe HDFN. At 17.77% of the total number of tested patients, which had only IgG1detected, was the reason for serious intensity of HDFN. The correlation of the titer to anti-D antibodies in the mother’s serum and the intensity of HDFN were researched in 48 newborns. The titers between 1:8 and 1:32 resulted in 3 cases of HDFN with symptoms of severe disease and in 4 cases there were no signs of HDFN. At 12 women that had a titre between 1:32 and 1:512, five of the newborns developed severe HDFN, and seven had symptoms of mild and weak intensity form. In 3 cases the titer was higher than 512, and out of them one newborn had weak symptoms of HDFN, one developed severe HDFN and one ended with foetal death. Only in one case the titer reached a value higher than 1000, and it ended with a fetal death.CONCLUSIONS: The titers of the pregnant women serum those are lower than 32 and those higher than 1000 can well predict HDFN. The titers of anti-D antibodies between 64 and 512 have no exact predictive value. IgG1 and IgG3 subclasses of anti-D have no predictive value by themselves, and cannot foresee the outcome of HDFN. The research study results suggest that IgG1 and IgG3 should be included in a multi – parameter protocol for evaluation of the HDFN intensity. They can give a real assessment of the expected HDFN intensity in combination with the titer hight and the significance of the antibodies.


The Lancet ◽  
1948 ◽  
Vol 252 (6527) ◽  
pp. 522-527 ◽  
Author(s):  
P.L. Mollison ◽  
M. Cutbush

2019 ◽  
Vol 41 (8) ◽  
pp. 632-634 ◽  
Author(s):  
Ryan A. Metcalf ◽  
Jenna Khan ◽  
Jennifer Andrews ◽  
Dennis Mayock ◽  
Zeenia Billimoria ◽  
...  

2002 ◽  
Vol 17 (1) ◽  
pp. 22-24 ◽  
Author(s):  
Claire Nicaise ◽  
Catherine Gire ◽  
Paul Casha ◽  
Claude d’Ercole ◽  
Cécile Chau ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document